Mycobacterium kyorinense Infection

Emerging Infectious Diseases

Volumn 19, Issue 3, 2013, Pages 508-510

  Ohnishi, Hiroaki ^a   Yonetani, Shota ^a   Matsushima, Satsuki ^a   Wada, Hiroo ^a   Takeshita, Kei ^b   Kuramochi, Daisuke ^c   Caldas, Paulo Cesar de Souza ^d   Campos, Carlos Eduardo Dias ^d   da Costa, Bianca Porphirio ^d   Ramos, Jesus Pais ^d   Mikura, Shinichirou ^e   Narisawa, Eriko ^e   Fujita, Akira ^e   Funayama, Yasunori ^f   Kobashi, Yoshihiro ^g   Sakakibara, Yumi ^h   Ishiyama, Yukako ^a   Takakura, Shunji ⁱ   Goto, Hajime ^a   Watanabe, Takashi ^a  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KITASATO UNIVERSITY   (Japan)

^c International University of Health and Welfare   (Japan)

^d Centro de Referencia Professor Helio Fraga   (Brazil)

^e TOKYO METROPOLITAN TAMA MEDICAL CENTER   (Japan)

^f UNIVERSITY OF TSUKUBA   (Japan)

^g KAWASAKI MEDICAL SCHOOL   (Japan)

^h Toshiba Hospital   (Japan)

ⁱ KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZITHROMYCIN; BIAPENEM; CLARITHROMYCIN; ETHAMBUTOL; ISONIAZID; LEVOFLOXACIN; MOXIFLOXACIN; RIFABUTIN; RIFAMPICIN; RNA 16S; RNA POLYMERASE BETA SUBUNIT; STREPTOMYCIN;

ANTIBIOTIC SENSITIVITY; BROTH DILUTION; DEATH; DRUG EFFICACY; GENE SEQUENCE; HUMAN; LETTER; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIOSIS; MYCOBACTERIUM; MYCOBACTERIUM KYORINENSE; NUCLEOTIDE SEQUENCE;

ANTITUBERCULAR AGENTS; GENES, BACTERIAL; GENETIC HETEROGENEITY; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MOLECULAR TYPING; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; PNEUMONIA, BACTERIAL; RETROSPECTIVE STUDIES; RNA, RIBOSOMAL, 16S;

EID: 84874268434     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1903.120591     Document Type: Letter

References (9)

1. Okazaki M, Ohkusu K, Hata H, Ohnishi H, Sugahara K, Kawamura C, et al. Mycobacterium kyorinense sp. nov., a novel, slow-growing species, related to Mycobacterium celatum, isolated from human clinical specimens. Int J Syst Evol Microbiol. 2009;59:1336-41. http://dx.doi.org/10.1099/ijs.0.000760-0
2. Wada H, Yamamoto M, Okazaki M, Watanabe T, Goto H. Isolation of Mycobacterium kyorinense in a patient with respiratory failure. Ann Intern Med. 2009;150:568-70.
3. Campos CED, Caldas PCS, Ohnishi H, Watanabe T, Ohtsuka K, Matsushima S, et al. First isolation of Mycobacterium kyorinense from clinical specimens in Brazil. J Clin Microbiol. 2012;50:2477-8. http://dx.doi.org/10.1128/JCM.00023-12
4. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. ATS Mycobacterial Diseases Subcommittee. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367-416. http://dx.doi.org/10.1164/rccm.200604-571ST
5. Reischl U, Feldmann K, Naumann L, Gaugler BJ, Ninet B, Hirschel B, et al. 16S rRNA sequence diversity in Mycobacterium celatum strains caused by presence of two different copies of 16S rRNA gene. J Clin Microbiol. 1998;36:1761-4.
6. Telenti A, Imboden P, Marchesi F, Lowrie D, Cole S, Colston MJ, et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet. 1993;341:647-51. http://dx.doi.org/10.1016/0140-6736(93)90417-F
7. Kim BJ, Lee SH, Lyu MA, Kim SJ, Bai GH, Chae GT, et al. Identification of mycobacterial species by comparative sequence analysis of the RNA polymerase gene (rpoB). J Clin Microbiol. 1999;37:1714-20.
8. Alekshun M, Kashlev M, Schwartz I. Molecular cloning and characterization of Borrelia burgdorferi rpoB. Gene. 1997;186:227-35. http://dx.doi.org/10.10 16/S0378-1119(96)00714-7
9. Gaurivaud P, Laigret F, Bove JM. Insusceptibility of members of the class Mollicutes to rifampin: studies of the Spiroplasma citri RNA polymerase b-subunit gene. Antimicrob Agents Chemother. 1996;40:858-62.